Agenda
- Welcome and Introduction
- The Metabolic Nature of Nash
-NASH pathophysiology
-Role of genetics, diet, and hormones
-Insulin resistance and hyperinsulinemia
-Metabolic syndrome and NASH
-Obesity as a risk factor for NASH
-The pathogenic relationship between diabetes and NASH
-Role of GLP-1 in NASH pathogenesis
- New Approaches to NASH Treatment
-Importance of early intervention
-Current treatment guidelines and pathways
-Addressing the metabolic complications associated with NASH
-Mechanism of action and early data with metabolic NASH therapies–
-GLP-1 receptor agonists
-PPAR agonists
-SGLT2 inhibitors
-Combination regimens
- Developing patient-personalized treatment plans
- Q&A and Discussion